M&A
Resetting Expectations for IFF's Pharma Exit
By Tom Terrarosa
|
Published: December 5th, 2023
The chemicals conglomerate is said to need a deal for its pharma business, but the market may deliver it a disappointment on valuation.
Insights & Analysis
Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.
Page 11
Activism
Adviser, Index Votes Show Contest Correlation
By Ronald Orol
|
Published: December 4th, 2023
Similarities between recommendations made by ISS and Glass Lewis and the votes of big index funds managers drive election outcomes.
Private Equity
On the Hunt: NMI Builds, Buys Payments Tech Stack
By Chris Nolter
|
Published: December 4th, 2023
Strategy chief Kate Hampton discusses NMI's latest acquisition, the appeal of carveouts and the company's M&A ambitions in payouts.
Podcasts
Behind the Buyouts: Investcorp's Tayeh on Backing Essential Services
By Nikitha Sattiraju
|
Published: November 27th, 2023
Investcorp head of North American private equity Dave Tayeh discusses backing middle market businesses that serve 'needs versus wants.'
M&A
Talking M&A: Competition Complexities
By The Deal Contributors
|
Published: November 20th, 2023
Following a number of crackdowns from global competition regulators, Baker McKenzie partners Duffy Lorenz and Creighton Macy share their experiences, insights and advice for clients looking to run a smooth deal process and minimize unexpected antitrust curveballs.
M&A
Drinks With The Deal: Albrecht Discusses Challenge of Balancing Life, Law
By David Marcus
|
Published: November 16th, 2023
Eli Albrecht, a partner at SMB Law Group, talks about creating an M&A practice outside of a large law firm on this week’s Drinks With The Deal podcast.
Activism
Activist Investing Today: White & Case’s Hu Talks M&A’s Unintended Consequences
By Ronald Orol
|
Published: November 14th, 2023
White & Case partner James Hu explains why activists frequently push for sales and divestitures and how a transaction without a shareholder vote can attract insurgent funds.
Podcasts
Drinks With The Deal: SPAC Sponsor Sloan Talks DraftKings
By Bill Meagher
|
Published: November 9th, 2023
Former Hollywood studio chairman Harry Sloan chose sponsoring SPACs for his second act.
Podcasts
Drinks With The Deal: Lebovitch Talks Retirement, What’s Next
By David Marcus
|
Published: November 3rd, 2023
Mark Lebovitch, a longtime shareholder plaintiffs lawyer, discusses his career, his recent decision to retire from his practice and what he may do next.
